Asia-Pacific radiopharmaceuticals market is expected to reach USD 2.73 billion by 2031 from USD 1.76 billion in 2023, growing at a CAGR of 5.7% in the forecast period of 2024 to 2031.
Asia-Pacific Radiopharmaceuticals Market Segmentation, By Type (Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals), Application (Diagnostic and Therapeutic), Drug Type (Generics and Branded), Source (Nuclear reactors, Cyclotrons, and others), End User (Hospitals, Diagnostic Centers, Cancer research institutes, Ambulatory surgical centers, and Others), Countries (China, Japan, Australia, South Korea, Singapore, India, Indonesia, Philippines, Malaysia, Vietnam, and rest of Asia-Pacific)- Industry Trends and Forecast to 2031
Overview of Asia-Pacific Radiopharmaceuticals Market Dynamics:
Driver • The growing demand for radiopharmceutical among diagnostics and clinical use Restraint • Stringent regulations for radiopharmecuticals
Opportunity • The rising research and development expenditure of radiopharmaceuticals Market Players:
The key market players operating in the Asia-Pacific radiopharmaceuticals market are listed below: • Cardinal Health • Lantheus • Curium • GE HealthCare
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of The Asia Pacific Radiopharmaceuticals Market
1.4 Limitations
1.5 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Currency And Pricing
2.5 Dbmr Tripod Data Validation Model
2.6 Multivariate Modelling
2.7 Primary Interviews With Key Opinion Leaders
2.8 Dbmr Market Position Grid
2.9 Market Testing Type Coverage Grid
2.10 Vendor Share Analysis
2.11 Secondary Sources
2.12 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Pestal Analysis
4.2 Porter Five Forces
5 Regulatory Scenario
6 Market Overview
6.1 Drivers
6.1.1 The Growing Demand For Radiopharmaceuticals In Diagnostics And Clinical Use
6.1.2 The Increasing Need For Pharmaceutical Products Across Varied Therapeutic Areas
6.1.3 The Increasing Prevalence Of Chronic Diseases
6.2 Restraints
6.2.1 Stringent Regulations For Radiopharmaceuticals
6.2.2 Potential Risks Associated With Radiopharmaceuticals
6.3 Opportunities
6.3.1 The Rising Research And Development Expenditure Of Radiopharmaceuticals
6.3.2 The Growing Incidences Of Complex Diseases In Geriatric Population
6.4 Challenges
6.4.1 High Cost Of Development And Implementation Of Radiopharmaceuticals
6.4.2 Lack Of Technical Expertise And High Cost For Training Existing Workforce
7 Asia-pacific Radiopharmaceuticals Market, By Drug Type
7.1 Overview
7.2 Branded
7.3 Generics
8 Asia-pacific Radiopharmaceuticals Market, By Type
8.1 Overview
8.2 Diagnostic Radiopharmaceuticals
8.2.1 Pet Radiopharmaceuticals
8.2.1.1 F-18
8.2.1.2 Ru-82
8.2.1.3 Other Pet Isotopes Radiopharmaceuticals
8.2.2 Spect Radiopharmaceuticals
8.2.2.1 Technetium-99m
8.2.2.2 Gallium-67
8.2.2.3 Iodine-123
8.2.2.4 Thallium-201
8.2.2.5 Other Spect Isotopes
8.3 Therapeutic Radiopharmaceuticals
8.3.1 Brachytherapy Isotopes
8.3.1.1 Iodine-125
8.3.1.2 Palladium-103
8.3.1.3 Cesium-131
8.3.1.4 Iridium-192
8.3.1.5 Other Brachytherapy Isotopes
8.3.2 Beta Emitters
8.3.2.1 Iodine-131
8.3.2.2 Luthetium-177
8.3.2.3 Samarium-153
8.3.2.4 Yttrium-90
8.3.2.5 Rhenium-186
8.3.2.6 Other Beta Emitters
8.3.3 Alpha Emitters
8.3.3.1 Ra-223
8.3.3.2 Others
9 Asia-pacific Radiopharmaceuticals Market, By Application
9.1 Overview
9.2 Diagnostic
9.2.1 Oncology
9.2.2 Cardiology
9.2.3 Neurology
9.2.4 Bone Scans
9.2.5 Thyroid Applications
9.2.6 Pulmonary Scans
9.2.7 Others
9.3 Therapeutic
9.3.1 Thyroid Indications
9.3.2 Bone Metastasis
9.3.3 Lymphoma
9.3.4 Endocrine Tumors
9.3.5 Other Indications
10 Asia-pacific Radiopharmaceuticals Market, By Source
10.1 Overview
10.2 Nuclear Reactors
10.3 Cyclotrons
10.4 Others
11 Asia-pacific Radiopharmaceuticals Market, By End User
11.1 Overview
11.2 Hospitals
11.2.1 Public
11.2.2 Private
11.2.2.1 Diagnostic Centers
11.2.2.2 Cancer Research Institutes
11.2.2.3 Ambulatory Surgical Centers
11.2.2.4 Others
12 Apac Radiopharmaceuticals Market, By Country
12.1 Asia-pacific
13 Asia-pacific Radiopharmaceuticals Market: Company Landscape
13.1 Company Share Analysis: Asia-pacific
14 Swot Analysis
15 Company Profile
15.1 Cardinal Health
15.1.1 Company Snapshot
15.1.2 Revenue Analysis
15.1.3 Product Portfolio
15.1.4 Recent Development
15.2 Advanced Accelerator Applications, A Novartis Company
15.2.1 Company Snapshot
15.2.2 Revenue Analysis
15.2.3 Product Portfolio
15.2.4 Recent Development
15.3 Lantheus
15.3.1 Company Snapshot
15.3.2 Revenue Analysis
15.3.3 Product Portfolio
15.3.4 Recent Development
15.4 Curium
15.4.1 Company Snapshot
15.4.2 Product Portfolio
15.4.3 Recent Development
15.5 Ge Healthcare
15.5.1 Company Snapshot
15.5.2 Revenue Analysis
15.5.3 Product Portfolio
15.5.4 Recent Development
15.6 Ansto
15.6.1 Company Snapshot
15.6.2 Product Portfolio
15.6.3 Recent Updates
15.7 Bayer Ag
15.7.1 Company Snapshot
15.7.2 Revenue Analysis
15.7.3 Product Portfolio
15.7.4 Recent Development
15.8 Bracco
15.8.1 Company Snapshot
15.8.2 Product Portfolio
15.8.3 Recent Development
15.9 Bwx Technologies. Inc.
15.9.1 Company Snapshot
15.9.2 Revenue Analysis
15.9.3 Product Portfolio
15.9.4 Recent Development
15.10 China Isotope & Radiation Corporation
15.10.1 Company Snapshot
15.10.2 Revenue Analysis
15.10.3 Product Portfolio
15.10.4 Recent Development
15.11 Eli Lilly And Company
15.11.1 Company Snapshot
15.11.2 Revenue Analysis
15.11.3 Product Portfolio
15.11.4 Recent Development
15.12 Eckert & Ziegler
15.12.1 Company Snapshot
15.12.2 Revenue Analysis
15.12.3 Product Portfolio
15.12.4 Recent Development
15.13 Global Medical Solutions
15.13.1 Company Snapshot
15.13.2 Product Portfolio
15.13.3 Recent Development
15.14 Eczacibaşi-monrol
15.14.1 Company Snapshot
15.14.2 Product Portfolio
15.14.3 Recent Development
15.15 Iba Worldwide
15.15.1 Company Snapshot
15.15.2 Revenue Analysis
15.15.3 Product Portfolio
15.15.4 Recent Development
15.16 Isotope Jsc
15.16.1 Company Snapshot
15.16.2 Product Portfolio
15.16.3 Recent Development
15.17 Jubilant Radiopharma A Jubilant Pharmova Company
15.17.1 Company Snapshot
15.17.2 Revenue Analysis
15.17.3 Product Portfolio
15.17.4 Recent Development
15.18 Mallinckrodt Pharmaceuticals
15.18.1 Company Snapshot
15.18.2 Revenue Analysis
15.18.3 Product Portfolio
15.18.4 Recent Updates
15.19 Ntp
15.19.1 Company Snapshot
15.19.2 Product Portfolio
15.19.3 Recent Development
15.20 Siemens Healthcare Gmbh
15.20.1 Company Snapshot
15.20.2 Revenue Analysis
15.20.3 Product Portfolio
15.20.4 Recent Development
15.21 Sterigenics U.S., Llc – A Sotera Health Company
15.21.1 Company Snapshot
15.21.2 Product Portfolio
15.21.3 Recent Developments
16 Questionnaire
17 Related Reports
Table 1 Asia-pacific Radiopharmaceuticals Market, By Drug Type, 2022-2031 (Usd Million)
Table 2 Asia-pacific Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 3 Asia-pacific Diagnostic Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 4 Asia-pacific Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 5 Asia-pacific Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2022-2031 (Volume In Mbq)
Table 6 Asia-pacific Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2022-2031 (Asp Per Mbq)
Table 7 Asia-pacific Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 8 Asia-pacific Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2022-2031 (Volume In Mbq)
Table 9 Asia-pacific Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2022-2031 (Asp Per Mbq)
Table 10 Asia-pacific Therapeutic Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 11 Asia-pacific Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 12 Asia-pacific Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2022-2031 (Volume In Mbq)
Table 13 Asia-pacific Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2022-2031 (Asp Per Mbq)
Table 14 Asia-pacific Beta Emitters In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 15 Asia-pacific Beta Emitters In Radiopharmaceuticals Market, By Type, 2022-2031 (Volume In Mbq)
Table 16 Asia-pacific Beta Emitters In Radiopharmaceuticals Market, By Type, 2022-2031 (Volume In Mbq)
Table 17 Asia-pacific Alpha Emitters In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 18 Asia-pacific Alpha Emitters In Radiopharmaceuticals Market, By Type, 2022-2031 (Volume In Mbq)
Table 19 Asia-pacific Alpha Emitters In Radiopharmaceuticals Market, By Type, 2022-2031 (Asp Per Mbq)
Table 20 Asia-pacific Radiopharmaceuticals Market, By Application, 2022-2031 (Usd Million)
Table 21 Asia-pacific Diagnostic In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 22 Asia-pacific Therapeutic In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 23 Asia-pacific Radiopharmaceuticals Market, By Source, 2022-2031 (Usd Million)
Table 24 Asia-pacific Radiopharmaceuticals Market, By End User, 2022-2031 (Usd Million)
Table 25 Asia-pacific Hospitals In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 26 Asia-pacific Radiopharmaceuticals Market, By Country, 2022-2031 (Usd Million)
Table 27 China Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 28 China Diagnostic Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 29 China Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 30 China Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2022-2031 (Volume In Mbq)
Table 31 China Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2022-2031 (Asp Per Mbq)
Table 32 China Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 33 China Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2022-2031 (Volume In Mbq)
Table 34 China Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2022-2031 (Asp Per Mbq)
Table 35 China Therapeutic Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 36 China Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 37 China Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2022-2031 (Volume In Mbq)
Table 38
Table 39 China Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2022-2031 (Asp Per Mbq)
Table 40 China Beta Emitters In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 41 China Beta Emitters In Radiopharmaceuticals Market, By Type, 2022-2031 (Volume In Mbq)
Table 42 China Beta Emitters In Radiopharmaceuticals Market, By Type, 2022-2031 (Asp Per Mbq)
Table 43 China Alpha Emitters In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 44 China Alpha Emitters In Radiopharmaceuticals Market, By Type, 2022-2031 (Volume In Mbq)
Table 45 China Alpha Emitters In Radiopharmaceuticals Market, By Type, 2022-2031 (Asp Per Mbq)
Table 46 China Radiopharmaceuticals Market, By Application, 2022-2031 (Usd Million)
Table 47 China Diagnostic In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 48 China Therapeutic In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 49 China Radiopharmaceuticals Market, By Drug Type, 2022-2031 (Usd Million)
Table 50 China Radiopharmaceuticals Market, By Source, 2022-2031 (Usd Million)
Table 51 China Radiopharmaceuticals Market, By End User, 2022-2031 (Usd Million)
Table 52 China Hospitals In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 53 Australia Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 54 Australia Diagnostic Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 55 Australia Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 56 Australia Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2022-2031 (Volume In Mbq)
Table 57 Australia Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2022-2031 (Asp Per Mbq)
Table 58 Australia Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 59 Australia Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2022-2031 (Volume In Mbq)
Table 60 Australia Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2022-2031 (Asp Per Mbq)
Table 61 Australia Therapeutic Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 62 Australia Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 63 Australia Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2022-2031 (Volume In Mbq)
Table 64 Australia Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2022-2031 (Asp Per Mbq)
Table 65 Australia Beta Emitters In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 66 Australia Beta Emitters In Radiopharmaceuticals Market, By Type, 2022-2031 (Volume In Mbq)
Table 67 Australia Beta Emitters In Radiopharmaceuticals Market, By Type, 2022-2031 (Asp Per Mbq)
Table 68 Australia Alpha Emitters In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 69 Australia Alpha Emitters In Radiopharmaceuticals Market, By Type, 2022-2031 (Volume In Mbq)
Table 70 Australia Alpha Emitters In Radiopharmaceuticals Market, By Type, 2022-2031 (Asp Per Mbq)
Table 71 Australia Radiopharmaceuticals Market, By Application, 2022-2031 (Usd Million)
Table 72 Australia Diagnostic In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 73 Australia Therapeutic In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 74 Australia Radiopharmaceuticals Market, By Drug Type, 2022-2031 (Usd Million)
Table 75 Australia Radiopharmaceuticals Market, By Source, 2022-2031 (Usd Million)
Table 76 Australia Radiopharmaceuticals Market, By End User, 2022-2031 (Usd Million)
Table 77 Australia Hospitals In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 78 Japan Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 79 Japan Diagnostic Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 80 Japan Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 81 Japan Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2022-2031 (Volume In Mbq)
Table 82 Japan Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2022-2031 (Asp Per Mbq)
Table 83 Japan Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 84 Japan Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2022-2031 (Volume In Mbq)
Table 85 Japan Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2022-2031 (Asp Per Mbq)
Table 86 Japan Therapeutic Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 87 Japan Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 88 Japan Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2022-2031 (Volume In Mbq)
Table 89 Japan Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2022-2031 (Asp Per Mbq)
Table 90 Japan Beta Emitters In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 91 Japan Beta Emitters In Radiopharmaceuticals Market, By Type, 2022-2031 (Volume In Mbq)
Table 92 Japan Beta Emitters In Radiopharmaceuticals Market, By Type, 2022-2031 (Asp Per Mbq)
Table 93 Japan Alpha Emitters In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 94 Japan Alpha Emitters In Radiopharmaceuticals Market, By Type, 2022-2031 (Volume In Mbq)
Table 95 Japan Alpha Emitters In Radiopharmaceuticals Market, By Type, 2022-2031 (Asp Per Mbq)
Table 96 Japan Radiopharmaceuticals Market, By Application, 2022-2031 (Usd Million)
Table 97 Japan Diagnostic In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 98 Japan Therapeutic In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 99 Japan Radiopharmaceuticals Market, By Drug Type, 2022-2031 (Usd Million)
Table 100 Japan Radiopharmaceuticals Market, By Source, 2022-2031 (Usd Million)
Table 101 Japan Radiopharmaceuticals Market, By End User, 2022-2031 (Usd Million)
Table 102 Japan Hospitals In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 103 South Korea Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 104 South Korea Diagnostic Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 105 South Korea Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 106 South Korea Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2022-2031 (Volume In Mbq)
Table 107 South Korea Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2022-2031 (Asp Per Mbq)
Table 108 South Korea Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 109 South Korea Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2022-2031 (Volume In Mbq)
Table 110 South Korea Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2022-2031 (Asp Per Mbq)
Table 111 South Korea Therapeutic Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 112 South Korea Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 113 South Korea Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2022-2031 (Volume In Mbq)
Table 114 South Korea Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2022-2031 (Asp Per Mbq)
Table 115 South Korea Beta Emitters In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 116 South Korea Beta Emitters In Radiopharmaceuticals Market, By Type, 2022-2031 (Volume In Mbq)
Table 117 South Korea Beta Emitters In Radiopharmaceuticals Market, By Type, 2022-2031 (Asp Per Mbq)
Table 118 South Korea Alpha Emitters In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 119 South Korea Alpha Emitters In Radiopharmaceuticals Market, By Type, 2022-2031 (Volume In Mbq)
Table 120 South Korea Alpha Emitters In Radiopharmaceuticals Market, By Type, 2022-2031 (Asp Per Mbq)
Table 121 South Korea Radiopharmaceuticals Market, By Application, 2022-2031 (Usd Million)
Table 122 South Korea Diagnostic In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 123 South Korea Therapeutic In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 124 South Korea Radiopharmaceuticals Market, By Drug Type, 2022-2031 (Usd Million)
Table 125 South Korea Radiopharmaceuticals Market, By Source, 2022-2031 (Usd Million)
Table 126 South Korea Radiopharmaceuticals Market, By End User, 2022-2031 (Usd Million)
Table 127 South Korea Hospitals In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 128 Singapore Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 129 Singapore Diagnostic Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 130 Singapore Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 131 Singapore Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2022-2031 (Volume In Mbq)
Table 132 Singapore Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2022-2031 (Asp Per Mbq)
Table 133 Singapore Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 134 Singapore Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2022-2031 (Volume In Mbq)
Table 135 Singapore Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2022-2031 (Asp Per Mbq)
Table 136 Singapore Therapeutic Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 137 Singapore Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 138 Singapore Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2022-2031 (Volume In Mbq)
Table 139 Singapore Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2022-2031 (Asp Per Mbq)
Table 140 Singapore Beta Emitters In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 141 Singapore Beta Emitters In Radiopharmaceuticals Market, By Type, 2022-2031 (Volume In Mbq)
Table 142 Singapore Beta Emitters In Radiopharmaceuticals Market, By Type, 2022-2031 (Asp Per Mbq)
Table 143 Singapore Alpha Emitters In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 144 Singapore Alpha Emitters In Radiopharmaceuticals Market, By Type, 2022-2031 (Volume In Mbq)
Table 145 Singapore Alpha Emitters In Radiopharmaceuticals Market, By Type, 2022-2031 (Asp Per Mbq)
Table 146 Singapore Radiopharmaceuticals Market, By Application, 2022-2031 (Usd Million)
Table 147 Singapore Diagnostic In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 148 Singapore Therapeutic In Radiopharmaceuticals Market, By Type, 2022-2031 (Usd Million)
Table 149 Singapore Radiopharmaceuticals Market, By Drug Type, 2022-2031 (Usd Million)
Figure 1 Asia Pacific Radiopharmaceuticals Market: Segmentation
Figure 2 Asia-pacific Radiopharmaceuticals Market: Data Triangulation